These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 33067269)

  • 21. Genome-wide CRISPR screens reveal a Wnt-FZD5 signaling circuit as a druggable vulnerability of RNF43-mutant pancreatic tumors.
    Steinhart Z; Pavlovic Z; Chandrashekhar M; Hart T; Wang X; Zhang X; Robitaille M; Brown KR; Jaksani S; Overmeer R; Boj SF; Adams J; Pan J; Clevers H; Sidhu S; Moffat J; Angers S
    Nat Med; 2017 Jan; 23(1):60-68. PubMed ID: 27869803
    [TBL] [Abstract][Full Text] [Related]  

  • 22. RNF43 G659fs is an oncogenic colorectal cancer mutation and sensitizes tumor cells to PI3K/mTOR inhibition.
    Fang L; Ford-Roshon D; Russo M; O'Brien C; Xiong X; Gurjao C; Grandclaudon M; Raghavan S; Corsello SM; Carr SA; Udeshi ND; Berstler J; Sicinska E; Ng K; Giannakis M
    Nat Commun; 2022 Jun; 13(1):3181. PubMed ID: 35676246
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Wnt addiction of genetically defined cancers reversed by PORCN inhibition.
    Madan B; Ke Z; Harmston N; Ho SY; Frois AO; Alam J; Jeyaraj DA; Pendharkar V; Ghosh K; Virshup IH; Manoharan V; Ong EH; Sangthongpitag K; Hill J; Petretto E; Keller TH; Lee MA; Matter A; Virshup DM
    Oncogene; 2016 Apr; 35(17):2197-207. PubMed ID: 26257057
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A phospho-switch controls RNF43-mediated degradation of Wnt receptors to suppress tumorigenesis.
    Tsukiyama T; Zou J; Kim J; Ogamino S; Shino Y; Masuda T; Merenda A; Matsumoto M; Fujioka Y; Hirose T; Terai S; Takahashi H; Ishitani T; Nakayama KI; Ohba Y; Koo BK; Hatakeyama S
    Nat Commun; 2020 Sep; 11(1):4586. PubMed ID: 32934222
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The E3 ligase RNF43 inhibits Wnt signaling downstream of mutated β-catenin by sequestering TCF4 to the nuclear membrane.
    Loregger A; Grandl M; Mejías-Luque R; Allgäuer M; Degenhart K; Haselmann V; Oikonomou C; Hatzis P; Janssen KP; Nitsche U; Gradl D; van den Broek O; Destree O; Ulm K; Neumaier M; Kalali B; Jung A; Varela I; Schmid RM; Rad R; Busch DH; Gerhard M
    Sci Signal; 2015 Sep; 8(393):ra90. PubMed ID: 26350900
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A ZNRF3-dependent Wnt/β-catenin signaling gradient is required for adrenal homeostasis.
    Basham KJ; Rodriguez S; Turcu AF; Lerario AM; Logan CY; Rysztak MR; Gomez-Sanchez CE; Breault DT; Koo BK; Clevers H; Nusse R; Val P; Hammer GD
    Genes Dev; 2019 Feb; 33(3-4):209-220. PubMed ID: 30692207
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Ub and Dub of RNF43/ZNRF3 in the WNT signalling pathway.
    Colozza G; Koo BK
    EMBO Rep; 2021 May; 22(5):e52970. PubMed ID: 33938624
    [TBL] [Abstract][Full Text] [Related]  

  • 28. ZNRF3 promotes Wnt receptor turnover in an R-spondin-sensitive manner.
    Hao HX; Xie Y; Zhang Y; Charlat O; Oster E; Avello M; Lei H; Mickanin C; Liu D; Ruffner H; Mao X; Ma Q; Zamponi R; Bouwmeester T; Finan PM; Kirschner MW; Porter JA; Serluca FC; Cong F
    Nature; 2012 Apr; 485(7397):195-200. PubMed ID: 22575959
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Post-translational Wnt receptor regulation: Is the fog slowly clearing?: The molecular mechanism of RNF43/ZNRF3 ubiquitin ligases is not yet fully elucidated and still controversial.
    Tsukiyama T; Koo BK; Hatakeyama S
    Bioessays; 2021 Apr; 43(4):e2000297. PubMed ID: 33569855
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The ubiquitin ligase RNF43 downregulation increases membrane expression of frizzled receptor in pancreatic ductal adenocarcinoma.
    Wang D; Tan J; Xu Y; Han M; Tu Y; Zhu Z; Dou C; Xin J; Tan X; Zeng JP; Zhao G; Liu Z
    Tumour Biol; 2016 Jan; 37(1):627-31. PubMed ID: 26240024
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Targeting Wnts at the source--new mechanisms, new biomarkers, new drugs.
    Madan B; Virshup DM
    Mol Cancer Ther; 2015 May; 14(5):1087-94. PubMed ID: 25901018
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Molecular genetics and targeted therapy of WNT-related human diseases (Review).
    Katoh M; Katoh M
    Int J Mol Med; 2017 Sep; 40(3):587-606. PubMed ID: 28731148
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Porcupine Inhibitor LGK974 Downregulates the Wnt Signaling Pathway and Inhibits Clear Cell Renal Cell Carcinoma.
    Li J; Wu G; Xu Y; Li J; Ruan N; Chen Y; Zhang Q; Xia Q
    Biomed Res Int; 2020; 2020():2527643. PubMed ID: 32104684
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Issues with RNF43 antibodies to reliably detect intracellular location.
    Li S; Zhang R; Lavrijsen M; van den Bosch TPP; Peppelenbosch MP; Smits R
    PLoS One; 2023; 18(4):e0283894. PubMed ID: 37023034
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Structures of Wnt-antagonist ZNRF3 and its complex with R-spondin 1 and implications for signaling.
    Peng WC; de Lau W; Madoori PK; Forneris F; Granneman JC; Clevers H; Gros P
    PLoS One; 2013; 8(12):e83110. PubMed ID: 24349440
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Ring finger protein 43 associates with gastric cancer progression and attenuates the stemness of gastric cancer stem-like cells via the Wnt-β/catenin signaling pathway.
    Gao Y; Cai A; Xi H; Li J; Xu W; Zhang Y; Zhang K; Cui J; Wu X; Wei B; Chen L
    Stem Cell Res Ther; 2017 Apr; 8(1):98. PubMed ID: 28446252
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Loss of RNF43 Function Contributes to Gastric Carcinogenesis by Impairing DNA Damage Response.
    Neumeyer V; Brutau-Abia A; Allgäuer M; Pfarr N; Weichert W; Falkeis-Veits C; Kremmer E; Vieth M; Gerhard M; Mejías-Luque R
    Cell Mol Gastroenterol Hepatol; 2021; 11(4):1071-1094. PubMed ID: 33188943
    [TBL] [Abstract][Full Text] [Related]  

  • 38. USP42 protects ZNRF3/RNF43 from R-spondin-dependent clearance and inhibits Wnt signalling.
    Giebel N; de Jaime-Soguero A; García Del Arco A; Landry JJM; Tietje M; Villacorta L; Benes V; Fernández-Sáiz V; Acebrón SP
    EMBO Rep; 2021 May; 22(5):e51415. PubMed ID: 33786993
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Structural and molecular basis of ZNRF3/RNF43 transmembrane ubiquitin ligase inhibition by the Wnt agonist R-spondin.
    Zebisch M; Xu Y; Krastev C; MacDonald BT; Chen M; Gilbert RJ; He X; Jones EY
    Nat Commun; 2013; 4():2787. PubMed ID: 24225776
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The structural basis of R-spondin recognition by LGR5 and RNF43.
    Chen PH; Chen X; Lin Z; Fang D; He X
    Genes Dev; 2013 Jun; 27(12):1345-50. PubMed ID: 23756651
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.